Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Accumulated Depreciation (2020 - 2022)

Immuneering has reported Accumulated Depreciation over the past 3 years, most recently at $418337.0 for Q4 2022.

  • Quarterly results put Accumulated Depreciation at $418337.0 for Q4 2022, up 140.12% from a year ago — trailing twelve months through Dec 2022 was $418337.0 (up 140.12% YoY), and the annual figure for FY2022 was $418337.0, up 140.12%.
  • Accumulated Depreciation for Q4 2022 was $418337.0 at Immuneering, up from $344556.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation for IMRX hit a ceiling of $418337.0 in Q4 2022 and a floor of $128752.0 in Q4 2020.
  • Median Accumulated Depreciation over the past 3 years was $198071.0 (2021), compared with a mean of $233887.4.
  • Biggest five-year swings in Accumulated Depreciation: skyrocketed 35.31% in 2021 and later surged 140.12% in 2022.
  • Immuneering's Accumulated Depreciation stood at $128752.0 in 2020, then skyrocketed by 35.31% to $174219.0 in 2021, then surged by 140.12% to $418337.0 in 2022.
  • The last three reported values for Accumulated Depreciation were $418337.0 (Q4 2022), $344556.0 (Q3 2022), and $276482.0 (Q2 2022) per Business Quant data.